A preliminary study on the impact and its mechanism of pharmaceutical regulation on the firm performance / 中国药学杂志
Chinese Pharmaceutical Journal
;
(24): 506-510, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-858049
ABSTRACT
OBJECTIVE:
To study the impact and its mechanism of pharmaceutical regulation on the firm performance.METHODS:
To make the multiple regression analysis with the pharmaceutical regulation intensity as independent variable, profit rate as dependent variable, R&D innovation and firm investment as intervening variable, based on the pharmaceutical industry data of China.RESULTS:
The relationship between the pharmaceutical regulation intensity and profit rate is significantly positive correlation, for which the R&D innocation plays a role of mediation.CONCLUSION:
Pharmaceutical regulation stimulates the R&D revenue and enhances technical innovation, and thus the innovation achievement enhances the firm performance. The increase of firm performance brought by innovation compensates the drop by regulation cost.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Pharmaceutical Journal
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS